Johann Entinger, DPM
Foot & Ankle Surgery · Rutland, VTNPI 1942567078
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,362 of the $2,747 with a category attached, or 86.0%. 7 manufacturers reported payments, led by Paragon 28, Inc. at 48.1% of the total. Reporting peaked in 2023 at $1,322 and has fallen 79.0% since, to $277 in 2025.
Across 15 payments — averaging $183.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$1K
- Medical Device Business Services, Inc.$1K
- Treace Medical Concepts, Inc.$277
- Osteomed LLC$21
- Baudax Bio Inc.$18
- DJO, LLC$16
- plus $14 from 1 others
What the payments were for
- Travel & lodging$2,36286%
- Food & beverage$36413%
- Education$211%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 5 | $1,322 |
| Medical Device Business Services, Inc. | 5 | $1,078 |
| Treace Medical Concepts, Inc. | 1 | $277 |
| Osteomed LLC | 1 | $21 |
| Baudax Bio Inc. | 1 | $18 |
| DJO, LLC | 1 | $16 |
| Stryker | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Portfolio$1,249
- LAPIPLASTY SYSTEM 1$277
How this compares
Too few foot & ankle surgery providers in Vermontto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 121 | $3,107 |
| Cephalexin | 35 | $396 |
| Clotrimazole | 16 | $319 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $291 |
| Doxycycline Hyclate | 19 | $179 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 26 | $113 |
| Gabapentin | 18 | $74 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Rutland
- Ian OdigieRutland$8K
- Ethan BuhlBrattleboro$5K
- Joseph WeaverWhite River Junction$5K
- Mark CharlsonSouth Burlington$3K
- Bryan MonierMorrisville$2K
- Lara StoneS. Burlington$735
- Maria IbanezBerlin$92
- McCamie PattersonBennington$46
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.